Last Price$228.1(1.8%)
Market Cap$16.9B
(1.9%)
Industry median - 2.7%
5Y Historical average - 10.7%
(15.0%)
Industry median - 24.8%
5Y Historical average - 21.1%
(15.6%)
Industry median - 25.1%
5Y Historical average - 23.1%
(33.3%)
Industry median - 25.2%
5Y Historical average - 11.6%
WST Growth Rating
WST Growth rating
5.0
WST Growth rating performance
WST Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with WST Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$16.9B | 5.0 | 9.5% | (1.9%) | 5.3% | 15.6% | (15.6%) | 10.7% | 2.8% | (33.3%) | |
$207.3B | 7.7 | 13.3% | 17.2% | 14.2% | 16.2% | 65.6% | 20.5% | (1.7%) | 43.7% | |
$66.3B | 5.9 | 3.5% | 5.9% | 9.0% | 17.0% | 41.9% | 145.1% | 0.7% | 10.9% | |
$46.6B | 5.8 | 5.7% | 3.6% | 2.8% | N/A | (26.4%) | 50.8% | 20.0% | 14.4% | |
$34.6B | 7.5 | 12.1% | 12.9% | 9.2% | 4.9% | (33.4%) | 35.4% | 27.0% | 47.1% | |
$18.6B | 5.4 | 8.0% | 8.4% | 5.8% | (26.9%) | 32.2% | 102.2% | (7.3%) | 34.0% | |
$17.9B | 4.1 | 2.5% | (14.0%) | 148.7% | N/A | 188.4% | N/A | (16.7%) | (45.3%) | |
$14.7B | 7.6 | 3.6% | 1.8% | 3.4% | 27.9% | 50.0% | 27.1% | 16.2% | 32.2% | |
$10.4B | 6.0 | 17.4% | 2.3% | 1.9% | N/A | N/A | 161.9% | (0.5%) | 2,170.3% | |
$9,757.8M | 6.7 | 4.6% | 2.7% | 5.0% | 8.2% | 30.2% | 4.4% | 5.5% | 36.0% | |
$8,979.7M | 7.2 | 19.5% | (8.0%) | 0.3% | N/A | N/A | 140.7% | 31.3% | 34.7% |
FAQ
What is the West Pharmaceutical Services, Inc. (WST) revenue growth?
The West Pharmaceutical Services, Inc. (WST) revenue growth is (1.9%), which is lower than the industry median of 2.7% and the 5-year historical average of 10.7%.
What is the West Pharmaceutical Services, Inc. (WST) operating income growth?
The West Pharmaceutical Services, Inc. (WST) operating income growth is (15.0%), compared to the industry median of 24.8% and the 5-year historical average of 21.1%.
What is the West Pharmaceutical Services, Inc. (WST) EPS (Earnings Per Share) growth?
The West Pharmaceutical Services, Inc. (WST) EPS growth is (15.6%), compared to the industry median of 25.1% and the 5-year historical average of 23.1%.
What is the West Pharmaceutical Services, Inc. (WST) Free Cash Flow (FCF) growth?
The West Pharmaceutical Services, Inc. (WST) Free Cash Flow growth is (33.3%), compared to the industry median of 25.2% and the 5-year historical average of 11.6%.